Signaling Pathways
-
A1404 Rigosertib sodium salt1 CitationTarget: PLKSummary: Plk1 inhibitor
-
A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
A2822 AC480 (BMS-599626)Target: EGFRSummary: HER1/2 inhibitor,selective and efficacious
-
A1684 AprepitantTarget: Substance P/NK1 ReceptorSummary: Substance P (SP) inhibitor
-
A2415 AcitretinTarget: RARsSummary: Metabolite of etretinate
-
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor
-
A1987 Ki164254 CitationTarget: LPA ReceptorsSummary: LPA receptor antagonist
-
A2487 Odanacatib (MK-0822)Target: CathepsinsSummary: Cathepsin K,potent and selective
-
A2278 NVP-AEW541Target: Insulin ReceptorSummary: IGF-IR inhibitor, novel, potent and selective